A Comprehensive Genomic Landscape for Pharma

Optimize Drug Discovery Pipelines with an Evidence-Based Genomic Landscape Around Every Disease

With a comprehensive landscape of genomic and related biomarkers tied to every disease, you can identify the genomics tied to your drug pathway. Leverage the world’s largest genomic knowledgebase to accelerate translational medicine, drug discovery, drug development, and better target clinical trials.
Genomenon-icon-search

GENOMIC BIOMARKER LANDSCAPE

A comprehensive, evidence-based landscape of all the genetic biomarkers associated with any disease that could influence your drug pathway

Genomenon-icon-literature

GENOMIC BIOMARKER CURATION

Complete reference citation reports for any genomic dataset, curated to ACMG/AMP guidelines to validate pathogenicity and clinical actionability

TALK TO US ABOUT YOUR NEEDS

Why Genomenon?

GENETIC EVIDENCE

GENETIC EVIDENCE

Never miss a biomarker that is critical to your success. Stay up to date with the most comprehensive biomarker landscape for every disease that is updated weekly.

FULL TEXT

FULL TEXT

Our comprehensive biomarker data comes with exhaustive citations from the full text of millions of articles, not just title and abstract like other tools

MACHINE LEARNING

MACHINE LEARNING

Save months or years of manual effort poring through the literature to find the genomic biomarkers you need

Services for Pharma


Services for Pharma

Acquire a Comprehensive Genomic Biomarker Landscape for Drug Development




Identify Critical Genomic Biomarkers for Clinical Trial Qualification

Services for Pharma



Services for Pharma

Connect Genomic Biomarkers to New Indications for Drug Repurposing

TALK TO US ABOUT YOUR NEEDS

Genomenon’s biomarker identification service hits a level of comprehensiveness unlike any other we’ve seen


Alastair Garfield, PhD, Vice President, Translational Research & Development (TRAD) Rhythm Pharmaceuticals
Alastair Garfield, PhD, Vice President, Translational Research & Development (TRAD) Rhythm Pharmaceuticals

Genomenon’s methodology improved the efficiency and completeness of our literature review process.


Alastair Garfield, PhD, Vice President, Translational Research & Development (TRAD) Rhythm Pharmaceuticals
Alastair Garfield, PhD, Vice President, Translational Research & Development (TRAD) Rhythm Pharmaceuticals

Learn How a Comprehensive Genomic Landscape can Accelerate Your Workflow